{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:10:16Z","timestamp":1779455416875,"version":"3.53.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Complete revascularization improves outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD); however, the optimal timing of noninfarct-related artery intervention during the index procedure, immediate revascularization (IR) versus a staged approach (SR), remains uncertain. We conducted a systematic review and meta-analysis of randomized controlled trials comparing SR and IR in patients with STEMI and MVD. The primary outcome was major adverse cardiovascular events. Secondary outcomes included all-cause and cardiovascular mortality, recurrent myocardial infarction, unplanned ischemia-driven revascularization, stent thrombosis, stroke, major bleeding, acute kidney injury, and heart failure hospitalization. Random-effects models with Hartung\u2013Knapp adjustment were used. Trial sequential analysis assessed evidence conclusiveness, and the certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation. Eight randomized trials, including 5077 patients (2556 SR; 2521 IR), were analyzed. No significant differences were observed between SR and IR for major adverse cardiovascular events [odds ratios (ORs), 1.07; 95% confidence intervals (CI), 0.76\u20131.49], recurrent myocardial infarction (OR, 1.30; 95% CI, 0.80\u20132.14), cardiovascular mortality (OR, 0.76; 95% CI, 0.51\u20131.13), or all-cause mortality (OR, 0.75; 95% CI, 0.54\u20131.06). Rates of stent thrombosis, stroke, unplanned ischemia-driven revascularization, major bleeding, acute kidney injury, and heart failure hospitalization were also comparable. Trial sequential analysis indicated insufficient information size to draw definitive conclusions, and the certainty of evidence ranged from very low to low. In patients with STEMI and MVD, staged and immediate complete revascularization provide comparable ischemic, safety, and mortality outcomes. Current evidence supports clinical equipoise, and revascularization timing should be individualized pending results from adequately powered trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000422","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:00:16Z","timestamp":1779454816000},"page":"e0422","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Staged Versus Immediate Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis"],"prefix":"10.1097","volume":"25","author":[{"given":"Mir W.","family":"Majeed","sequence":"first","affiliation":[{"name":"VMMC and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Humayun","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Missouri, Kansas City, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruvi K.","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Narendra Modi Medical College and Sheth L.G. Hospital, Ahmedabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khubaib Mohammad","family":"Murtafa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Government Medical College, Srinagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Consoli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Federal University of Bahia, Salvador, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Arif","sequence":"additional","affiliation":[{"name":"Department of Medicine, Government Medical College, Srinagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya S.","family":"Khanday","sequence":"additional","affiliation":[{"name":"Department of Medicine, Government Medical College, Srinagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit V.","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Department of Medicine, First Faculty of Medicine, Charles University, Prague, Czechia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano G.","family":"Ruelas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Instituto de Investigacion Nutricional (IIN), Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Waleed","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Ratan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Patna Medical College and Hospital, Patna, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shariq A.","family":"Wani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wayne State University, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bismah A.","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Zehra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jawaharlal Nehru Medical College, Aligarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Baqal","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin R.","family":"Mantoo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AIIMS New Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid H.","family":"Changal","sequence":"additional","affiliation":[{"name":"Department of Medicine, MercyOne Siouxland Medical Center, Sioux City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraschandra","family":"Vallabhajosyula","sequence":"additional","affiliation":[{"name":"Department of Medicine, Warren Alpert Medical School of Brown University and Brown University Health Cardiovascular Institute, Providence, RI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"80","DOI":"10.17925\/HI.2020.14.2.80","article-title":"ST-elevation myocardial infarction and multivessel coronary artery disease - a critical review of current practice, evidence and meta-analyses.","volume":"14","author":"Figini","year":"2020","journal-title":"Heart Int"},{"key":"R2-20260522","first-page":"CD011986","article-title":"Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.","volume":"5","author":"Bravo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3\u2014PRIMULTI): an open-label, randomised controlled trial.","volume":"386","author":"Engstr\u00f8m","year":"2015","journal-title":"Lancet"},{"key":"R4-20260522","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes.","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"R6-20260522","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(23)00351-3","article-title":"Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.","volume":"401","author":"Diletti","year":"2023","journal-title":"Lancet"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa2307823","article-title":"Timing of complete revascularization with multivessel PCI for myocardial infarction.","volume":"389","author":"St\u00e4hli","year":"2023","journal-title":"N Engl J Med"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(25)01529-6","article-title":"Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.","volume":"406","author":"Kim","year":"2025","journal-title":"Lancet"},{"key":"R9-20260522","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2512918","article-title":"Immediate or deferred nonculprit-lesion PCI in myocardial infarction.","volume":"394","author":"Nijveldt","year":"2026","journal-title":"N Engl J Med"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjcard.2024.12.013","article-title":"Meta-analysis comparing immediate versus staged complete revascularization for ST-elevation myocardial infarction with multivessel disease.","volume":"239","author":"Almizel","year":"2025","journal-title":"Am J Cardiol"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"e035535","DOI":"10.1161\/JAHA.124.035535","article-title":"Immediate versus staged complete revascularization for patients with ST-segment-elevation myocardial infarction and multivessel disease: a network meta-analysis of randomized trials.","volume":"13","author":"Elbadawi","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3390\/jcm13237107","article-title":"A meta-analysis of timing of complete revascularization in patients with ST-elevation myocardial infarction.","volume":"13","author":"Kuzemczak","year":"2024","journal-title":"J Clin Med"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence.","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.4244\/EIJ-D-23-00882","article-title":"Immediate versus staged complete revascularisation in patients presenting with STEMI and multivessel disease.","volume":"20","author":"Scarparo","year":"2024","journal-title":"EuroIntervention"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5152\/AnatolJCardiol.2021.71080","article-title":"A clinical trial comparing complete revascularization at the time of primary percutaneous coronary intervention versus during the index hospital admission in patients with multi-vessel coronary artery disease and STEMI uncomplicated by cardiogenic shock.","volume":"25","author":"Brendea","year":"2021","journal-title":"Anatol J Cardiol"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ahj.2023.01.020","article-title":"Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.","volume":"259","author":"Park","year":"2023","journal-title":"Am Heart J"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/hrt.2009.177162","article-title":"A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up.","volume":"96","author":"Politi","year":"2010","journal-title":"Heart"},{"key":"R21-20260522","first-page":"57","article-title":"Two preventive multivessel stenting strategy with zotarolimus eluting stents in STelevation myocardial infarction patients: 12-month results of randomized trial.","volume":"9","author":"Tarasov","year":"2017","journal-title":"Interv Cardiol"},{"key":"R22-20260522","doi-asserted-by":"crossref","first-page":"e016575","DOI":"10.1161\/JAHA.120.016575","article-title":"Optimal revascularization strategy in non-ST-segment-elevation myocardial infarction with multivessel coronary artery disease: culprit-only versus one-stage versus multistage revascularization.","volume":"9","author":"Kim","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R23-20260522","first-page":"102449","article-title":"Revascularization strategies for multivessel disease in acute coronary syndrome: network meta-analysis.","volume":"4","author":"Harmouch","year":"2025","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"R24-20260522","doi-asserted-by":"crossref","first-page":"e70011","DOI":"10.1002\/clc.70011","article-title":"Impact of immediate versus staged complete revascularization on short-term and long-term clinical outcomes in patients with acute coronary syndrome and multivessel disease: a systematic review and meta-analysis.","volume":"47","author":"Jia","year":"2024","journal-title":"Clin Cardiol"},{"key":"R25-20260522","doi-asserted-by":"crossref","first-page":"e230421189013","DOI":"10.2174\/1573403X16999201210195702","article-title":"Myocardial infarction with and without ST-segment elevation: a contemporary reappraisal of similarities and differences.","volume":"17","author":"Mitsis","year":"2021","journal-title":"Curr Cardiol Rev"},{"key":"R26-20260522","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"R28-20260522","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/CIRCULATIONAHA.117.028782","article-title":"Angiography versus hemodynamics to predict the natural history of coronary stenoses: fractional flow reserve versus angiography in multivessel evaluation 2 substudy.","volume":"137","author":"Ciccarelli","year":"2018","journal-title":"Circulation"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:00:19Z","timestamp":1779454819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000422","relation":{},"ISSN":["1535-2811"],"issn-type":[{"value":"1535-2811","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}